1).29,32 With respect to the vascular system, rGLP-1 activation induces modest decreases in blood pressure,33,34 it has a vasodilator effect, improves arterial stiffness, and prevents atherosclerotic plaque formation-and has plaque stabilizing effects-through its anti-inflammatory and antiapoptotic effects as demonstrated in animal models.29,32,3538 Despite controversies about rGLP-1 expression in vascular smooth muscle and endothelial cells, studies have shown that arGLP-1 has antiproliferative effects on these cells,39 reduces oxidative stress, improves endothelial function, and increases nitric oxide production in experimental models.3540 In the heart they produce a discrete increase in heart rate (24 beats/min), although this does not seem to be associated with an increase in arrhythmias or cardiovascular events

Second, kidney injury in diabetes appears to be related to glomerular hyperfiltration [93, 94], which is likely related to an excessive reabsorption of sodium in the proximal tubule, leading diminished delivery of sodium to the macula densa, and (via tubuloglomerular feedback) to afferent arteriolar dilatation [95, 96]
Lower doses may reduce gastrointestinal side effects, but this remains speculative
For breastfeeding , the FDA notes that there are no data on semaglutide presence in human milk, effects on the breastfed infant, or effects on milk production
CLICK HERE TO DOWNLOAD THE FOX NEWS APP "And then I realized the very first time I took the GLP-1 that oh, theyre not even thinking about it
Gala GLP-1 connects patients with licensed healthcare providers who independently evaluate eligibility for treatment